Prediction of infusion capacity to deliver Alzheimer’s disease treatments in the United States relative to expected demand
This is my archive
System readiness and the patient care pathway for Alzheimer’s disease diagnosis and treatment
Expected wait times for access to a disease-modifying Alzheimer’s treatment in England: A modelling study
Current Capacity for Diagnosing Alzheimer’s Disease in Germany and Implications for Wait Times
Estimates of Current Capacity for Diagnosing Alzheimer’s Disease in Sweden and the Need to Expand Specialist Numbers
Estimated Investment Need to Increase England’s Capacity to Diagnose Eligibility for an Alzheimer’s Treatment to G7 Average Capacity Levels
Estimates of Current Capacity for Diagnosing Alzheimer’s Disease in Sweden and the Need to Expand Specialist Numbers
Projected Savings to Canadian Provincial Budgets from Reduced Long-Term Care Home Utilization Due to a Disease-Modifying Alzheimer’s Treatment
Expected wait times for access to a disease-modifying Alzheimer’s treatment in England: A modelling study
Detection Rates of Mild Cognitive Impairment in Primary Care for the United States Medicare Population
